Latest News on PowerShares Dynamic Retail (PMR) ETF

  • Mid-Day ETF Update: ETFs, Stocks Continue to Hit Record Highs on Election ... [December 9 2016 10:56 AM]
  • Mid-Day ETF Update: ETFs, Stocks Continue to Hit Record Highs on Election ...   Nasdaq - Dec 9, 2016 Consumer Discretionary Select Sector SPDR (XLY) and retail funds SPDR S&P Retail (XRT), PowerShares Dynamic Retail (PMR) and Market Vectors Retail ETF (RTH) were in positive territory. Eros International (EROS) was up 7.5% after the company said ... Read more about this PowerShares Dynamic Retail (PMR) news
  • KR Crosses Above Key Moving Average Level [December 9 2016 09:00 AM]
  • KR Crosses Above Key Moving Average Level   Nasdaq - Dec 9, 2016 In trading on Friday, shares of Kroger Co (Symbol: KR) crossed above their 200 day moving average of $34.45, changing hands as high as $34.47 per share. Read more about this PowerShares Dynamic Retail (PMR) news


  • Mid-Day ETF Update: ETFs, Stocks Higher, Shrugging Off Slump in Health Care as ... [December 7 2016 10:36 AM]
  • Mid-Day ETF Update: ETFs, Stocks Higher, Shrugging Off Slump in Health Care as ...   Nasdaq - Dec 7, 2016 Consumer Discretionary Select Sector SPDR (XLY) and retail funds SPDR S&P Retail (XRT), PowerShares Dynamic Retail (PMR) and Market Vectors Retail ETF (RTH) were in positive territory. Dave & Buster's Entertainment (PLAY) was up 17.8% after it ... Look Who's Turnin... Read more about this PowerShares Dynamic Retail (PMR) news


  • Mid-Day ETF Update: ETFs, Stocks Mostly Higher as Crude Rally, Upbeat Economic ... [December 1 2016 10:33 AM]
  • Mid-Day ETF Update: ETFs, Stocks Mostly Higher as Crude Rally, Upbeat Economic ...   Nasdaq - Dec 1, 2016 Consumer Discretionary Select Sector SPDR (XLY) and retail funds SPDR S&P Retail (XRT), PowerShares Dynamic Retail (PMR) and Market Vectors Retail ETF (RTH) were in negative territory. Tilly's (TLYS) rose 35.4% to an 18-month high after reporting Q3 ... Read more about this PowerShares Dynamic Retail (PMR) news
  • PharmaMar Presents Positive Results With Its Conjugated Antibody MI130110 in CD13-Expressing Tumor-Cells [December 1 2016 12:00 AM]
  • [PR Newswire] - PharmaMar (PHM), a world leader in the discovery, development and commercialization of new antitumor compounds of a marine origin, has announced that its antibody-drug conjugate (ADC) has demonstrated a remarkable in vitro antitumoral activity in a CD13, fibrosarcoma positive animal model. MI130110 is formed by a compound of marine origin (PM050489) that has been conjugated to a mo... Read more about this PowerShares Dynamic Retail (PMR) news
  • PharmaMar Begins a Phase I Study of PM1183 in Japan for the Treatment of Solid Tumors [November 28 2016 06:05 AM]
  • [PR Newswire] - PharmaMar (PHM) has announced the start of an open-label, multicenter, Phase I study in Japan to evaluate the recommended dose (RD) of PM1183 (lurbinectedin) in patients with certain types of unresectable/advanced solid tumors. The main objective of the study is to determine the recommended dose of PM1183 in Japanese patients. Furthermore, the secondary objective will be to evaluat... Read more about this PowerShares Dynamic Retail (PMR) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center